BioMedEcon Reports Six Times Higher Psychiatric Medication Costs among
Patients with OCD Compared to Depression
MOSS BEACH, Calif.--(BUSINESS WIRE)--Sep 2, 2008 - BioMedEcon Group, a
leading provider of health economics and outcomes research, presented
findings of a unique nine-year retrospective claims analysis that
compared the per-patient, median healthcare costs of newly-diagnosed
patients with obsessive-compulsive disorder (OCD) to matched patients
with depression.
Powered by LSoft's LISTSERV(R) list management software